Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: A naturalistic study

A. John Rush, Harold A. Sackeim, Lauren B. Marangell, Mark S. George, Stephen K. Brannan, Sonia M. Davis, Phil Lavori, Robert Howland, Mitchel A. Kling, Barry Rittberg, Linda Carpenter, Philip Ninan, Francisco Moreno, Thomas Schwartz, Charles Conway, Michael Burke, John J. Barry

Research output: Contribution to journalArticlepeer-review

263 Scopus citations

Abstract

Background: The need for effective, long-term treatment for recurrent or chronic, treatment-resistant depression is well established. Methods: This naturalistic follow-up describes outpatients with nonpsychotic major depressive (n = 185) or bipolar (I or II) disorder, depressed phase (n = 20) who initially received 10 weeks of active (n = 110) or sham vagus nerve stimulation (VNS) (n = 95). The initial active group received another 9 months, while the initial sham group received 12 months of VNS. Participants received antidepressant treatments and VNS, both of which could be adjusted. Results: The primary analysis (repeated measures linear regression) revealed a significant reduction in 24-item Hamilton Rating Scale for Depression (HRSD 24) scores (average improvement, .45 points [SE = .05] per month (p < .001). At exit, HRSD 24 response rate was 27.2% (55/202); remission rate (HRSD 24 ≤ 9) was 15.8% (32/202). Montgomery Äsberg Depression Rating Scale (28.2% [57/202]) and Clinical Global Impression-Improvement (34.0% [68/200]) showed similar response rates. Voice alteration, dyspnea, and neck pain were the most frequently reported adverse events. Conclusions: These 1-year open trial data found VNS to be well tolerated, suggesting a potential long-term, growing benefit in treatment-resistant depression, albeit in the context of changes in depression treatments. Comparative long-term data are needed to determine whether these benefits can be attributed to VNS.

Original languageEnglish (US)
Pages (from-to)355-363
Number of pages9
JournalBiological Psychiatry
Volume58
Issue number5
DOIs
StatePublished - Sep 1 2005

Keywords

  • Clinical trial
  • Efficacy
  • Major depressive disorder, Bipolar disorder
  • Side effects
  • Treatment-resistant depression (TRD)
  • Vagus nerve stimulation (VNS)

ASJC Scopus subject areas

  • Biological Psychiatry

Fingerprint Dive into the research topics of 'Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: A naturalistic study'. Together they form a unique fingerprint.

Cite this